Vyne Therapeutics approves 1-for-50 reverse stock split for Nasdaq listing

Vyne Therapeutics Inc. announced a 1-for-50 reverse stock split and a special cash dividend of $17.3 million ahead of its pending merger with Yarrow Bioscience, facilitating the combined company's transition to the ticker YARW.